Genes such as non‐muscle myosin heavy chain 9 (MYH9), apolipoprotein L1 (APOL1), apolipoprotein E (APOE), SPARC‐related modular calcium‐binding 2 (SMOC2), Telomerase reverse transcriptase (TERT), collagen type IV (COL4), and uromodulin (UMOD), among others, have been implicated in CKD risk across diverse population [14]. This evidence concerns the gene APOL1 and chronic kidney disease.